PNTG Stock Analysis: Buy, Sell, or Hold?
PNTG - The Pennant Group, Inc. Common Stock
$38.88
-0.12 (-0.31%)
▼
5d:
-1.12%
30d:
-2.34%
90d:
+12.4%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When PNTG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PNTG shows positive signals but monitor for confirmation. Market pricing in 3.6% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: PNTG shows positive signals but monitor for confirmation. Market pricing in 3.6% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$52.74
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$32.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PNTG is currently trading at $38.88, which is considered slightly low relative to its 30-day fair value range of $38.82 to $41.10. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.5) compared to its historical average (22.0). At these levels, the market is pricing in 3.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PNTG is in a strong uptrend. The price is currently testing key support at $37.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PNTG scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $46.67 (+20.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PNTG is in a strong uptrend. The price is currently testing key support at $37.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PNTG scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $46.67 (+20.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$38.82 -
$41.10
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
91.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (66/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($46.67)
- NEUTRAL: Market pricing in 3.6% annual earnings growth - fairly valued
- BULLISH: Bottoming setup score 66/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$38.82 -
$41.10
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$3.65
(9.4%)
Support & Resistance Levels
Support Level
$37.96
Resistance Level
$40.55
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.50
Wall Street Target
$46.67
(+20.0%)
Revenue Growth (YoY)
35.8%
Earnings Growth (YoY)
25.0%
Profit Margin
2.9%
Valuation Premium vs History
+3.6% premium
PE vs Historical
24.5 vs 22.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$40.28
(+4%)
2-Year Target
$41.73
(+7%)
3-Year Target
$43.23
(+11%)
3-Yr Target (if PE normalizes)
(PE: 25→22)
PE COMPRESSION
$38.82
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.5, Growth: 13.3%)
$56.47
(+45%)
Base:
(SPY PE: 20.1, Growth: 13.3%)
$46.27
(+19%)
Bear:
(PE: 17.1, Growth: 13.3%)
$39.33
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 42.86 | Current EPS (TTM): $0.91
Bull Case
$74.82
(+92%)
Analyst growth 74.4%, PE expands to 47.1
Base Case
$68.02
(+75%)
Market implied 74.4%, PE stable at 42.9
Bear Case
$26.52
(-32%)
Severe decline -20.0%, PE contracts to 36.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 5:35 PM ET
Data refreshes hourly during market hours. Next update: 6:35 PM
Data refreshes hourly during market hours. Next update: 6:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PNTG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
